Antifungal Activities of Phenolic Compounds Against Candida Albicans and Their Structure-Activity Relationship
SUN Shu-juan,GUO Huai-fang,LOU Hong-xiang,GE Wei-ying,LI Hong-jian,SU Le-qun,MA Bin,LING Xiao,FAN Pei-hong
DOI: https://doi.org/10.3969/j.issn.1672-979x.2006.03.009
2006-01-01
Abstract:Objective To identify active compounds which have antifungal activity or can work synergistically with fluconazole on Candida albicans. Methods The antifungal activities of 8 phenolic compounds isolated from natural resources and 6 semi-synthetic phenolic derivatives against 18 strains of new clinical isolated Candida albicans were evaluated according to NCCLS M27-A broth microdilution protocol. The combination antifungal effects of some active tested compounds with fluconazole were also investigated. Results Compound albicanyl caffeate displayed strong antifungal property with MIC 4 μg/ml, while moderate antifungal effects (MIC16 μg/ml)were observed with compounds emodin, resveratrol, 3,4'-difluorostilbene, 2,2'-difluorostilbene and 2,3',5'-trifluorostilbene. Pakyonol, catechin, ampelopsin A, 3,4,4'-trihydroxyl- bibenzyl, 2,4'-difluorostilbene, 4-fluorostilbene,2-methyloxy-4'-fluorostilbene showed lower activity with MIC 32 μ g/ml. Synergetic antifungal effects were observed in the combination of albicanyl caffeate or 3,4'-difluorostilbene and fluconazole, whereas additive antifungal effects were revealed when catechin or resveratrol combined with fluconazole. Conclusion The tested phenolic compounds possess potent anti-candidal activities, and some of them work synergistically or additively with fluconazole. They may play an important role in the treatment of Candida albicans infections.